New genetic testing for children with neuroblastoma
Scientists at the Institute of Cancer Research and Royal Marsden Hospital have developed a new genetic test that will be given to children with solid tumours in an effort to analyse genetic changes in 81 cancer genes, with funding from Christopher Smile.
Solving Kids' Cancer visit CRUK Clinical Trials Unit
Leona and James from the Solving Kids’ Cancer team visited the CRUK Clinical Trials Unit (CTU) based at the University of Birmingham this month.
Solving Kids' Cancer UK join European movement Unite2Cure
Solving Kids’ Cancer recently joined the European movement Unite2Cure, which is a parent-led network of groups and individuals from across Europe calling for better treatment and improved access to treatment for children and young people with cancer.
Statement on NICE Interim Unituxin Decision
As you may have heard, last week the National Institute for Health and Care Excellence (NICE) released a statement to say they are considering not approving the drug Unituxin (dinutuximab) for high-risk neuroblastoma patients.
NICE Consultation
As you may already be aware the NICE (National Institute for Health and Care Excellence) recently published interim guidance that dinutuximab (Unituxin, ch14.18/SP2/0) in combination with GM-CSF and IL-2 is not recommended for use on the NHS.
